Xilio Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Xilio Therapeutics, Inc. has filed 351 SEC EDGAR filings since 21 Jan 2021

SEC filing history

Showing 151-175 of 351 matching filings.

Per page
25
Current page
7
EFFECT File 333-279015

EFFECT filing

Filing date
06 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-279015

UPLOAD filing

Filing date
02 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-279015

S-3

Filing date
30 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-40925

ARS

Filing date
25 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40925

DEFA14A

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40925

DEF 14A

Filing date
25 Apr 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-268264

424B5

Filing date
15 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92962

SC 13G

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92962

SC 13G/A filing

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
03 Apr 2024
Reporting date
02 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
03 Apr 2024
Reporting date
27 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-278427

S-8

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92962

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92962

AMENDMENT NO. 2

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92962

AMENDMENT NO. 1

Filing date
05 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .